Cargando…
Changing prostaglandin E2 (PGE(2)) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE(2) receptor EP2 and EP4
PURPOSE: We investigated the change, if any, in prostaglandin E2 (PGE(2)) signaling in endometriotic lesions of different developmental stages in mouse. In addition, we evaluated the effect of treatment of mice with induced deep endometriosis (DE) with inhibitors of PGE(2) receptor subtypes EP2 and...
Autores principales: | Huang, Qingqing, Liu, Xishi, Guo, Sun‐Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660993/ https://www.ncbi.nlm.nih.gov/pubmed/34938150 http://dx.doi.org/10.1002/rmb2.12426 |
Ejemplares similares
-
A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE(2)-mediated immunosuppression and inhibits breast cancer metastasis
por: Ma, Xinrong, et al.
Publicado: (2013) -
COX-2-PGE(2)-EPs in gynecological cancers
por: Ye, Yao, et al.
Publicado: (2020) -
Pharmacological modulation of prostaglandin E(2) (PGE(2)) EP receptors improves cardiomyocyte function under hyperglycemic conditions
por: Bosma, Karin J., et al.
Publicado: (2022) -
Role of the PGE(2) receptor subtypes EP1, EP2, and EP3 in repetitive traumatic brain injury
por: Catlin, James, et al.
Publicado: (2019) -
Effect of selective inhibition or activation of PGE2 EP1 receptor on glomerulosclerosis
por: Chen, Xu, et al.
Publicado: (2020)